Diagnostics Revolutions

Diagnostics Revolutions
  • Pininvest Analysis

By highlighting well respected companies providing systems for in-vitro diagnostics, including gene sequencing machines, and related services, we focus on advanced medical equipment used in clinical applications, in laboratories and in research.

The fastest growing areas, gene analysis techniques and splicing applied to fields of human identity testing, oncology research, infectious disease research, pharmacogenomics, and inherited disease boost research and product innovation in molecular biology (identifying potential drug targets), microbiology (defining how organisms evolve), medicine (tracking genetic diseases) and plant sciences

The breath of the applications with potential breakthrough in areas as diverse as healthcare, agriculture or environmental protection has opened vast opportunities for start-up companies applying the new technologies… but major uncertainties about commercial break-through leaves the potential investor exposed to extreme risk situations

To service the diagnostics market (evaluated at $ 60 billion and expected to continue to grow by 4% during the coming 5 years), manufacturers of the advanced medical equipment are placed on a strong footing

Diagnostics Revolutions • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Vol. Risk Contrib. MDD
 
Accelerate Diagnostics AXDX NASDAQ Health Care Lab Analytical Instruments USD 11.22 620 M -47.5% 85%   6% -78%
Agilent Technologies A NYSE Health Care Medical Laboratories & Research USD 99.38 31 B 28.4% 36%   3% -30%
Bio-Rad Laboratories BIO NYSE Health Care Lab Analytical Instruments USD 513.48 15 B 48.7% 38%   3% -22%
Bio-Techne TECH NASDAQ Health Care Diagnostics USD 243.90 9.3 B 22.2% 36%   3% -27%
Bruker Corporation BRKR NASDAQ Health Care Lab Analytical Instruments USD 38.63 6.0 B -10.9% 50%   4% -41%
Cancer Genetics CGIX NASDAQ Health Care Diagnostics USD 4.39 10 M 36.8% 182%   7% -76%
Danaher DHR NYSE Conglomerates Industrial Conglomerates USD 206.31 144 B 41.3% 33%   3% -28%
Exact Sciences EXAS NASDAQ Health Care Diagnostics USD 77.47 12 B -25.5% 70%   5% -64%
Guardant Health GH NASDAQ Health Care Diagnostics USD 102.50 10 B 38.6% 62%   4% -34%
HTG Molecular Diagnostics HTGM NASDAQ Health Care Specialized Medical Devices USD 0.36 22 M -53.9% 88%   3% -70%
Illumina ILMN NASDAQ Health Care Gene Editing - Cell Therapies USD 295.50 43 B -4.5% 44%   3% -38%
Laboratory Corporation Of America LH NYSE Health Care Diagnostics USD 183.40 18 B 6.2% 51%   5% -47%
Lantheus Holdings LNTH NASDAQ Health Care Medical Consumables & Intermediates USD 12.92 514 M -51.0% 66%   5% -66%
NanoString Technologies NSTG NASDAQ Health Care Diagnostics USD 46.02 1.7 B 89.0% 81%   7% -56%
NeoGenomics NEO NASDAQ Health Care Gene Editing - Cell Therapies USD 35.83 3.8 B 64.1% 60%   5% -41%
OPKO Health OPK NASDAQ Health Care Diagnostics USD 3.17 2.1 B 56.9% 99%   6% -50%
Pacific Biosciences of California PACB NASDAQ Health Care Medical Technology USD 8.13 1.3 B 44.4% 74%   5% -58%
Perkinelmer PKI NYSE Health Care Lab Analytical Instruments USD 118.20 13 B 36.9% 35%   3% -34%
Quest Diagnostics Inc. DGX NYSE Health Care Diagnostics USD 113.87 15 B 8.0% 40%   3% -36%
Quidel Corp QDEL NASDAQ Health Care Diagnostics USD 189.31 8.0 B 194.9% 75%   3% -50%
Sonic Healthcare SKHHY OTC Health Care Diagnostics USD 23.56 - 25.9% 45%   4% -41%
Thermo Fisher Scientific TMO NYSE Health Care Lab Analytical Instruments USD 429.05 169 B 45.1% 36%   3% -25%
Veracyte VCYT NASDAQ Health Care Gene Editing - Cell Therapies USD 32.72 1.6 B 23.5% 71%   5% -47%
Waters WAT NYSE Health Care Lab Analytical Instruments USD 195.47 12 B -14.5% 39%   3% -33%